These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 12050542
21. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Vickers MA, Satyanarayana R. Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279 [Abstract] [Full Text] [Related]
29. Epistaxis after sildenafil. Bott SR, Shergill I, Arya M. J R Soc Med; 2002 Oct; 95(10):528. PubMed ID: 12356992 [No Abstract] [Full Text] [Related]
30. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. Briganti A, Salonia A, Deho' F, Zanni G, Barbieri L, Rigatti P, Montorsi F. World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417 [Abstract] [Full Text] [Related]
31. Vardenafil--PDE5 inhibitor number 3. Jackson G. Int J Clin Pract; 2004 Mar; 58(3):229. PubMed ID: 15117087 [No Abstract] [Full Text] [Related]
32. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait. Kassim AA, Fabry ME, Nagel RL. Blood; 2000 Mar 01; 95(5):1878-9. PubMed ID: 10744389 [No Abstract] [Full Text] [Related]
33. Cardiovascular data on sildenafil citrate: introduction. Zusman RM. Am J Cardiol; 1999 Mar 04; 83(5A):1C-2C. PubMed ID: 10078536 [No Abstract] [Full Text] [Related]
34. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Kloner RA. Circulation; 2004 Nov 09; 110(19):3149-55. PubMed ID: 15533876 [No Abstract] [Full Text] [Related]